AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report)’s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $3.22 and traded as high as $4.30. AIkido Pharma shares last traded at $3.95, with a volume of 176,146 shares trading hands.
AIkido Pharma Price Performance
The firm’s 50-day simple moving average is $6.06 and its 200 day simple moving average is $3.22. The firm has a market capitalization of $21.67 million, a price-to-earnings ratio of -1.02 and a beta of 0.93.
AIkido Pharma Company Profile
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Further Reading
- Five stocks we like better than AIkido Pharma
- Retail Stocks Investing, Explained
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- How to Invest in Blue Chip Stocks
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- What Do S&P 500 Stocks Tell Investors About the Market?
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
